 | Marc Rodwin Professor of Law - Suffolk University Law School |
-
03.07.2014-29.08.2014
Reforming Drug Policy & the Pharmaceutical Industry
Marc André Rodwin. Expected Outcomes: Reforming Drug Policy & the Pharmaceutical Industry I will analyze how improper dependencies and misaligned incentives contribute to several problems related to the development and use of prescription drugs. I will also propose reform options to address those problems and analyze their advantages and disadvantages. One problem area concerns ways to appropriately target public subsidies for research and product development. A second problem area concerns aligning incentives for private R & D to address public policy goals. A third problem concerns the integrity of scientific knowledge, clinical research and medical practice due to manufacturer control over clinical trials. A fourth problem concerns patient safety and public health due to incentives for drug firms and their managers. A fifth problem concerns bias due to discretionary industry financing of professional medical activities. I will also use my summer residency to synthesize my research, start my book manuscript, and complete one or two major articles. During my residency I hope to be able to collaborate with local experts who have written about pharmaceutical issues, conflicts of interest, and health law and bioethics. Among these scholars are Valerie Junod and Philippe Ducor (Université de Genève faculté de droit) Dominique Sprumonte, (Institut de droit de la santé,, Université de Neuchâtel) and individuals at the WHO who are working on bioethics, clinical trials, and public health issues (including, Dr. Marie-Charlotte Bouesseau, Dr. Andreas Reis, and Dr. Abha Saxena, in Ethics and Health, Dept. of Ethics and Social Determinants of Health).
Marc A. Rodwin, Professor of Law at Suffolk University Law School, is the author of Conflicts of Interest and the Future of Medicine: The United States, France and Japan (Oxford, 2011); and Medicine, Money and Morals: Physicians’ Conflicts of Interest (Oxford, 1993). ). Rodwin has testified before Congress and state legislatures and served on government commissions and advisory boards, including the Food and Drug Administration and the Indiana Commission on Hospital Antitrust. He has participated in meetings of the National Academy of Sciences, Institute of Medicine.
Rodwin has been a lab fellow at the Edmond J. Safra Center, Harvard University, a research scholar at Tokyo University Law School, and the Centre National de la Recherche Scientifique (CNRS) in France, and a visiting professor at several French universities. Before his appointment at Suffolk University, he was Associate Professor at Indiana University School of Public and Environmental Affairs. Previously he practiced law. He has received grants from the German Marshall Fund, the Fulbright Fellowship, the Social Science Research Council (Abe Fellowship), and Robert Wood Johnson Foundation Investigator Award. He has lectured in Japan, Canada, France, Mexico, Switzerland, Tunisia and the U.K.
Rodwin has testified before Congress and state legislatures and served on government commissions and advisory boards, including the Food and Drug Administration and the Indiana Commission on Hospital Antitrust. He has participated in meetings sponsored by the National Academy of Sciences-Institute of Medicine, the American Bar Association, the Agency for Health Care Policy and Research, the American College of Physicians, the Health Care Financial Management Association, the National Health Policy Forum and other groups. Rodwin has assisted the Consumer Federation of America, Public Citizen Health Research Group, and other health care consumer groups.
Suffolk University Web Page:
http://www.law.suffolk.edu/faculty/directories/faculty.cfm?InstructorID=48
marcrodwin@gmail.com
SSRN Publication Page:
http://ssrn.com/author=625249
Previous